Table 1.
Inhibitory potencies of selected drugs on fluorescein uptake in ciPTEC-OAT1.
Drug | IC50 (µM) a | R Square b | Therapeutic Concentrations (µM) [44] |
---|---|---|---|
ACEIs | |||
Captopril | 2022 ± 465 | 0.5557 | 0.2–5 |
Enalaprilate | 1853 ± 370 | 0.6753 | 0.04–0.4 |
Lisinopril | not available | 0.1671 | 0.01–0.16 |
ARBs | |||
Losartan | 3.1 ± 0.7 | 0.8713 | 0.5–1.5 |
Valsartan | 11.5 ± 3.5 | 0.9374 | 2–14 |
Diuretics | |||
Furosemide | 28.1 ± 9.1 | 0.9301 | 6–30 |
Statins | |||
Pravastatin | 13.8 ± 8.5 | 0.8757 | 0.08–0.3 [45]; 0.43 [46,47] |
Simvastatin | 21.3 ± 3.8 | 0.8613 | 0.006–0.014 [44]; 0.55 [46,47] |
H2RA | |||
Cimetidine | 887.6 ± 198.4 | 0.7441 | 1–16 |
a Data are expressed as mean ± SD. b Curves were obtained after non-linear regression analysis. Abbreviations: ACEIs = angiotensin-converting enzyme inhibitors; ARBs = angiotensin receptor blockers; H2RA = histamine H2 receptor antagonists, IC50 = half maximal inhibitory concentration.